Asagi, Akinori <br/><br/>
Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.  [electronic resource] 

 -  Pancreas  Jan 2013 
 - 11-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1536-4828 
<br/><br/><label>Standard No.: </label>10.1097/MPA.0b013e3182550d77  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Pancreatic Ductal--diagnostic imaging<br/>Diagnosis, Differential<br/>Female<br/>Fluorodeoxyglucose F18<br/>Humans<br/>Linear Models<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Multimodal Imaging<br/>Neoplasm Invasiveness<br/>Neoplasm Recurrence, Local--diagnostic imaging<br/>Neoplasm Staging<br/>Pancreatic Neoplasms--diagnostic imaging<br/>Positron-Emission Tomography<br/>Predictive Value of Tests<br/>Radiopharmaceuticals<br/>Retrospective Studies<br/>Tomography, X-Ray Computed<br/>Treatment Outcome<br/>Tumor Burden<br/>Whole Body Imaging